Try the modernized beta website. Learn more about the modernization effort.
Working… Menu

A Study of Baricitinib (LY3009104) in Participants With Rheumatoid Arthritis (RA-BRIDGE)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT03915964
Recruitment Status : Active, not recruiting
First Posted : April 16, 2019
Last Update Posted : June 24, 2022
Incyte Corporation
Information provided by (Responsible Party):
Eli Lilly and Company

No Study Results Posted on for this Study
Recruitment Status : Active, not recruiting
Estimated Primary Completion Date : April 14, 2025
Estimated Study Completion Date : February 1, 2026